The simple changes that could prevent three in five liver cancer cases
The Lancet Commission on liver cancer found that three in five liver cancer cases could be prevented by reducing alcohol consumption and obesity and by increasing uptake of the hepatitis vaccine.
The number of new liver cancers around the world will rise from 0.87 million in 2022 to 1.52 million in 2050, according to the experts' projections.
The proportion of cases of liver cancer linked to obesity are set to increase from 5 per cent to 11 per cent, the group said.
By 2050, some 21 per cent of liver cancers will be caused by alcohol, they said.
And 11 per cent will be caused by a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD) – formerly known as fatty liver disease, where fat builds up in a person's liver.
The severe form of this condition is called metabolic dysfunction-associated steatohepatitis.
The research team said that 60 per cent of liver cancers are preventable.
They said that global deaths from liver cancer are expected to rise from 760,000 in 2022 to 1.37 million in 2050.
'These data suggest that preventive measures targeting a comprehensive number of risk factors for hepatocellular carcinoma are sorely needed,' the team of experts, led by academics in Hong Kong, wrote.
The main treatment for MASLD is eating a balanced diet, being physically active and potentially losing weight.
'Liver cancer is a growing health issue around the world,' said Professor Jian Zhou, chairman of the Commission from Fudan University in China.
'It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5 per cent to 30 per cent.
'We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend.'
First author, Professor Stephen Chan, from the Chinese University of Hong Kong, added: 'As three in five cases of liver cancer are linked to preventable risk factors, mostly viral hepatitis, alcohol and obesity, there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer and save lives.'
Commenting on the study, Pamela Healy, chief executive of the British Liver Trust, said: 'Liver cancer is the fastest rising cause of cancer death in the UK, and just 13 per cent of people diagnosed will survive for five years or more.
'We know that the biggest risk factors are having pre-existing liver cirrhosis or viral hepatitis, and this new analysis highlights that MASLD, also known as fatty liver disease, is expected to be linked to an increasing number of cases.
'As well as improving early detection through surveillance of people with cirrhosis, it is essential that we tackle these underlying causes and prioritise public health.
'By supporting people to maintain a healthy weight, cut down on alcohol and get tested and treated for hepatitis, we can prevent many cases of liver cancer and save lives.'
In 2022, some 64 per cent of adults in England were estimated to be overweight or obese.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medical News Today
an hour ago
- Medical News Today
Your FAQs around generalized pustular psoriasis
Generalized pustular psoriasis is a severe form of psoriasis that can cause body-wide symptoms and may require immediate medical pustular psoriasis (GPP), also known as von Zumbusch psoriasis, is a rare type of GPP affects an estimated 1 to 7 people out of every million. It features episodes or 'flares' of erythroderma, widespread skin inflammation and redness or other skin color changes. These flares develop with sterile (not caused by infection), fluid-filled blisters or a flare, pustules break open, and the skin can become dry and painful. It may crack, peel, or scale and may resemble a is an immune-mediated condition caused by dysfunction in the immune system. Unusual immune responses to triggers such as stress, medication use, or infections can set off a chain of severe inflammatory reactions throughout the body. GPP often has identifiable triggers, but it can also happen without any obvious people experience severe systemic symptoms in addition to skin inflammation, including fever, chills, muscle weakness, and fatigue. If left untreated, GPP can cause life threatening complications like organ on to find out the answers to some of your most pressing questions about is the outlook for generalized pustular psoriasis?GPP is a chronic condition. It can be managed, but it may never be fully cured. As many as 80% of people experience relapses, and most have at least one episode outlook during a flare depends largely on how quickly a person receives treatment. Severe inflammation can cause tissue damage and affect internal organs like the heart, lungs, or kidneys. In some cases, this may result in sepsis, a life threatening complication that requires urgent care. Seeking treatment as soon as possible can help shorten the duration of a GPP flare and lower the risk of serious between flares, GPP can affect long-term health. People with GPP have a higher risk of cardiovascular conditions and other systemic complications, which can affect quality of life and life to a 2025 study, people with GPP have about four times the risk of death from any cause compared to the general is the best treatment for generalized pustular psoriasis?Everyone living with GPP has different factors that can affect their treatment plan. A doctor will consider a person's age, family history, genetics, and other health conditions when recommending a flare, first-line treatments usually include medications that target the immune system. These drugs work by blocking or calming overactive inflammatory example is spesolimab (Spevigo), a monoclonal antibody that blocks interleukin-36 (IL-36) receptors. IL-36 is a pro-inflammatory molecule, known as a cytokine, that becomes overactive in GPP. It triggers systemic inflammation and stimulates the production of neutrophils, which accumulate in the skin and create spesolimab is the only medication approved by the Food and Drug Administration (FDA) specifically for the treatment of may also use other medications that modify immune responses or control inflammation, such as:infliximaboral retinoidsapremilastmethotrexatecyclosporineFor mild symptoms or when GPP is well managed, doctors may recommend more conservative treatments. These can include keeping the skin hydrated, using topical corticosteroids, and prescribing antibiotics if there is an a medication triggers the flare, stopping that medication is also an important part of the do you stop pustules from spreading?Immediate treatment helps stop GPP pustules from in GPP are sterile. They form because of overactive inflammatory processes in the body. Itching pustules or having pustules break open is not what causes pustules to spread (although this can increase the risk of secondary infection).Interrupting the inflammatory chain with medications like spesolimab during a flare will help bring pustules under control. Applying cool compresses, keeping skin clean and moisturized, and avoiding irritants like rough fabric can help improve the overall health of the skin and manage pustular psoriasis lead to sepsis?Generalized pustular psoriasis can lead to is a severe, life threatening inflammatory reaction to an infection that spreads through the bloodstream. It can cause symptoms such as: feverrapid heartbeatrapid breathinga dangerous drop in blood pressureconfusionorgan damageIn GPP, several factors can increase the risk of sepsis. Open skin from pustules, cracks, or scratching allows bacteria, viruses, or fungi to cross the skin barrier and enter the bloodstream. Medications that suppress the immune system, such as methotrexate or infliximab, can also make it harder for the body to fight these pathogens enter the bloodstream, they can travel throughout the body, triggering a widespread inflammatory response known as sepsis happen during every generalized pustular psoriasis flare?Sepsis can occur during a flare, but it does not happen every time a person with GPP experiences a in GPP are believed to be caused by a 'cytokine storm.' A cytokine storm happens when the immune system becomes overactive and releases too many pro-inflammatory molecules at once. Infection can trigger a cytokine storm, but it is not the only cause. Cytokine storms in GPP can happen any time the immune system is overactivated, even without an however, always results from an infection. It also involves a cytokine storm, but in this case, the overactivation of cytokines is a direct response to that infection. In conditions like GPP, existing cytokine dysfunction can make a sepsis-related cytokine storm more pustular psoriasis is a rare form of psoriasis that causes widespread areas of red, inflamed skin covered with sterile, fluid-filled pustules. GPP can be life threatening. It causes severe, body-wide inflammation that may damage tissues and lead to organ treatment can help slow the spread of pustules and lower the risk of serious complications. Doctors typically treat GPP with medications that interrupt or block overactive immune responses. Spesolimab (Spevigo) is the only drug currently approved by the FDA specifically for the treatment of GPP.
The Independent
4 hours ago
- The Independent
Eating cumin can help reduce the risk of heart disease
Cumin, a versatile spice, is rich in antioxidants that can help reduce the risk of heart disease and other chronic illnesses. Grinding cumin seeds enhances the body's absorption of its beneficial vitamins (B, E) and minerals (iron, magnesium). Studies suggest cumin extract may alleviate symptoms of irritable bowel syndrome and improve liver function in non-alcoholic fatty liver disease. Historically used for thousands of years, cumin has become one of the most widely used spices globally. While some research indicates potential benefits for weight loss and cholesterol reduction, dietitians note that more studies are required to confirm these effects. The ancient spice that reduces bloating - and could boost weight loss
The Independent
5 hours ago
- The Independent
Pfizer CEO says pharmaceutical companies want to work with Trump to make medicine more affordable
Pfizer CEO Albert Bourla announced that major pharmaceutical companies are ready to work with the Trump administration to make medicines more affordable and directly available to consumers. This move comes after Trump demanded that 17 drugmakers expand direct-to-consumer options and lower prices to match those in other industrialized countries, threatening to use 'every tool' if they did not comply. Pfizer and Bristol Myers Squibb have already revealed plans to offer their blood thinner Eliquis at a lower price online, building on Pfizer's existing direct-to-consumer telehealth and prescription services. Other companies, such as Eli Lilly and Novo Nordisk, are also exploring direct access for their obesity drugs, aiming to bypass pharmacy benefit managers. Despite potential sector-specific tariffs on pharmaceutical imports, which could escalate to 250 percent, Pfizer expects to meet its financial forecasts, though experts have refuted Trump's claims of significant drug price reductions.
